These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 20004292)

  • 21. Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
    de Groot T; Doornebal J; Christensen BM; Cockx S; Sinke AP; Baumgarten R; Bedford JJ; Walker RJ; Wetzels JFM; Deen PMT
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F669-F676. PubMed ID: 28615247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.
    Bedford JJ; Weggery S; Ellis G; McDonald FJ; Joyce PR; Leader JP; Walker RJ
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1324-31. PubMed ID: 18596116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperosmolar nonketotic coma precipitated by lithium-induced nephrogenic diabetes insipidus.
    Azam H; Newton RW; Morris AD; Thompson CJ
    Postgrad Med J; 1998 Jan; 74(867):39-41. PubMed ID: 9538487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Between efficiency and toxicity: the case of a patient improved by lithium who developed iatrogenic nephropathy].
    Autret L; Meynard JA; Sanchez MF; Bernadet R; Charpin C
    Encephale; 1999; 25(5):485-7. PubMed ID: 10598313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review and practical guideline for the prevention and management of the renal side effects of lithium therapy.
    Schoot TS; Molmans THJ; Grootens KP; Kerckhoffs APM
    Eur Neuropsychopharmacol; 2020 Feb; 31():16-32. PubMed ID: 31837914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Progressive renal failure caused by lithium nephropathy].
    Presne C; Fakhouri F; Kenouch S; Stengel B; Kreis H; Grünfeld JP
    Presse Med; 2002 May; 31(18):828-33. PubMed ID: 12148451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lower serum levels of lithium may produce efficacy without adverse effects.
    Shim SS
    Am J Geriatr Psychiatry; 2009 Jul; 17(7):625; author reply 625-6. PubMed ID: 19546659
    [No Abstract]   [Full Text] [Related]  

  • 28. [Monitoring mood regulating drugs in bipolar disorder].
    Millet B; Vanelle JM
    Encephale; 2006 Sep; 32 Pt 2():S536-41. PubMed ID: 17099570
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of Long-Term Lithium Treatment on Renal Function in Patients With Bipolar Disorder Based on Novel Biomarkers.
    Dastych M; Synek O; Gottwaldová J
    J Clin Psychopharmacol; 2019; 39(3):238-242. PubMed ID: 30932947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lithium carbonate maintenance therapy in a hemodialysis patient with end-stage renal disease.
    Knebel RJ; Rosenlicht N; Colllins L
    Am J Psychiatry; 2010 Nov; 167(11):1409-10. PubMed ID: 21041259
    [No Abstract]   [Full Text] [Related]  

  • 31. A decision analysis of long-term lithium treatment and the risk of renal failure.
    Werneke U; Ott M; Renberg ES; Taylor D; Stegmayr B
    Acta Psychiatr Scand; 2012 Sep; 126(3):186-97. PubMed ID: 22404233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergency treatment of lithium-induced diabetes insipidus with nonsteroidal anti-inflammatory drugs.
    Lam SS; Kjellstrand C
    Ren Fail; 1997 Jan; 19(1):183-8. PubMed ID: 9044466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lithium in the over-65s--a dedicated monitoring service leads to a better quality of treatment supervision.
    Fielding S; Kerr S; Godber C
    Int J Geriatr Psychiatry; 1999 Nov; 14(11):985-7. PubMed ID: 10556872
    [No Abstract]   [Full Text] [Related]  

  • 34. Lithium-induced nephrogenic diabetes insipidus.
    Eustatia-Rutten CF; Tamsma JT; Meinders AE
    Neth J Med; 2001 Mar; 58(3):137-42. PubMed ID: 11246113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Renal and metabolic complications of lithium].
    Kanfer A; Blondiaux I
    Nephrologie; 2000; 21(2):65-70. PubMed ID: 10798206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.
    de Groot T; Sinke AP; Kortenoeven ML; Alsady M; Baumgarten R; Devuyst O; Loffing J; Wetzels JF; Deen PM
    J Am Soc Nephrol; 2016 Jul; 27(7):2082-91. PubMed ID: 26574046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium-induced nephrogenic diabetes insipidus.
    Imam SK; Hasan A; Shahid SK
    J Pak Med Assoc; 2005 Mar; 55(3):125-7. PubMed ID: 15852752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrogenic diabetes insipidus in a lethargic lithium-treated patient.
    Meinardi JR; Donders SH
    Neth J Med; 1997 Mar; 50(3):105-9. PubMed ID: 9121593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitizing the insensitive.
    Ashrafian H; Bogle RG
    Clin Nephrol; 2004 Jun; 61(6):440-3. PubMed ID: 15224809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intravenous ketoprofen for severe lithium-induced polyuria].
    Tran-Van D; Avargues P; Labadie P; Hervé Y; Dardare E; Fontaine B
    Presse Med; 2005 Sep; 34(16 Pt 1):1137-40. PubMed ID: 16208259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.